|
|
|
|
| LEADER |
01632naa a2200397 i 4500 |
| 001 |
NSK01001151111 |
| 003 |
HR-ZaNSK |
| 005 |
20221012102020.0 |
| 007 |
ta |
| 008 |
221012s2019 ci a | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)001151111
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b hrv
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 616
|2 2011
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 100 |
1 |
|
|a Budeč, Maja
|4 aut
|
| 245 |
1 |
0 |
|a Verification of authenticity of Ginkgo Biloba l. leaf extract and its products present on the Croatian market by analysis of quantity and ratio of Ginkgo flavone glycosides (quercetin, kaempferol and isorhamnetin) to terpene trilactones to the effect of unmasking counterfeit drugs endangering patient health /
|c Maja Budeč, Jasna Bošnir, Aleksandar Racz, Dario Lasić, Danijel Brkić, Ana Mosović Ćuić, Željka Kuharić, Gordana Jurak and Lidija Barušić.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 36 jed.
|
| 504 |
|
|
|a Sažetak.
|
| 653 |
|
0 |
|a Ginkgo biloba L.
|a Kvercetin
|a Krivotvoreni lijekovi
|
| 653 |
|
5 |
|a Hrvatska
|
| 700 |
1 |
|
|a Bošnir, Jasna
|4 aut
|
| 700 |
1 |
|
|a Racz, Aleksandar
|4 aut
|
| 700 |
1 |
|
|a Lasić, Dario
|4 aut
|
| 700 |
1 |
|
|a Brkić, Danijel,
|c sanitarni inženjer
|4 aut
|
| 700 |
1 |
|
|a Mojsović Ćuić, Ana
|4 aut
|
| 700 |
1 |
|
|a Kuharić, Željka
|4 aut
|
| 700 |
1 |
|
|a Jurak, Gordana
|4 aut
|
| 700 |
1 |
|
|a Barušić, Lidija
|4 aut
|
| 773 |
0 |
|
|t Acta clinica Croatica (Tisak)
|x 0353-9466
|g 58 (2019), 4 ; str. 672-691
|w nsk.(HR-ZaNSK)000006735
|
| 981 |
|
|
|b B18/19
|
| 998 |
|
|
|b gtao2210
|
| 856 |
4 |
1 |
|u https://hrcak.srce.hr/235169
|y Elektronička verzija članka
|